Companies: 10,795·Total market cap: $144.5T
Jaguar Health, Inc.

Jaguar Health, Inc.

JAGXNASDAQHealthcare● Active
$2.73
$-0.07(-2.50%)
Market Cap$181927
P/E Ratio
52W High$137.2
52W Low$2.53
Overview

Jaguar Health, Inc.(JAGX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · JAGX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$11.51M$11.69M$9.76M$11.96M$4.33M
Cost of Revenue$3.77M$1.96M$2.04M$2.02M$2.33M
Gross Profit$7.74M$9.73M$7.72M$9.94M$2.00M
Gross Margin %(computed)67.21%83.27%79.13%83.11%46.18%
Operating Expenses
R&D Expenses$24.97M$16.54M$18.60M$17.65M$15.08M
G&A Expenses$18.64M$16.33M$16.59M$17.87M$17.10M
Total Operating Expenses$53.65M$40.56M$42.02M$44.35M$42.71M
Operating Income($45.91M)($30.83M)($34.29M)($34.41M)($40.71M)
Operating Margin %(computed)-398.82%-263.76%-351.31%-287.85%-939.05%
Interest Income$0.00M$0.00M$0.00M$0.00M$8.42M
Interest Expense($0.07M)$0.23M$6.38M$12.72M$8.42M
Income Before Tax($54.00M)($39.25M)($41.90M)($48.40M)($52.60M)
Income Tax Expense($0.42M)$0.00M$0.00M$0.00M$0.00M
Net Income($53.58M)($38.49M)($41.30M)($47.45M)($52.59M)
Net Margin %(computed)-465.42%-329.30%-423.11%-396.91%
Per Share & EBITDA
EPS (Basic)$-803.95$-4574.07$-93992.00$-1899528.00$-4631759.00
Wtd Avg Shares0.07M0.01M0.00M0.00M0.00M
EBITDA($45.91M)($36.66M)($32.76M)($33.38M)($42.37M)
EBITDA Margin %(computed)-398.82%-313.65%-335.62%-279.19%-977.30%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Jaguar Health, Inc.

关于Jaguar Health, Inc.(JAGX)损益表

Jaguar Health, Inc.(JAGX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,JAGX实现营收$0.01B,毛利润$0.01B(毛利率67.21%),净利润($0.05B)(净利率-465.42%)。

常见问题

JAGX · 4 问

Jaguar Health, Inc.(JAGX)2025财年营收为$0.01B,同比down1.5%。

JAGX revenueJAGX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09